Raluca Alexandru

7PUBLICATIONS
93CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 07, 2026
TNFR1 expression on cancer cells mediates immune escape and an immunosuppressive microenvironment.

|Aug 25, 2026
CD137 agonists in mice suppress germinal center responses by increasing the immunosuppressive activity of follicular regulatory T-cells.

|Jul 22, 2026
CD70 Overexpression at Diagnosis Predicts Relapse and supports dual CD19-CD70 CAR-T Therapy in Follicular Lymphoma.

|Jan 16, 2026
Safety, Feasibility, and Pharmacodynamic Activity of Intratumoral Injections of the Agonist Anti-CD137 (4-1BB) mAb Urelumab in Combination with Nivolumab.

Miguel F Sanmamed, Carlos E de Andrea, David Ruiz-Guillamon

|Nov 13, 2025
The Proteomic Landscape of CTNNB1 Mutated Low-Grade Early-Stage Endometrial Carcinomas.

Alvaro Lopez-Janeiro, Emilia Brizzi, Ignacio Ruz-Caracuel

|May 19, 2025
A Phase II Study of Perioperative Avelumab plus Chemotherapy for Patients with Resectable Gastric Cancer or Gastroesophageal Junction Cancer - The MONEO Study.

Maria Alsina, Guillermo Villacampa, Carlos de Andrea

Pageof 2

Frequent Collaborators

6 joint publications

Carlos E de Andrea

5 joint publications

Ignacio Melero

3 joint publications

Gabriel Gomis

3 joint publications

Carlos Luri-Rey